Portfolio company
Informuta
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Informuta develops a predictive software platform using genomic sequencing and artificial intelligence to forecast antibiotic resistance in bacteria for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
Insentio
The company develops artificial intelligence technology for the rapid identification of infectious bacteria to assist healthcare providers and laboratories.
Biotia
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
Claryx
Claryx develops a genomic surveillance platform that sequences pathogen DNA to detect and trace infection outbreaks for hospitals and healthcare systems.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Discuva
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
